This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Food and Drug Administration ( FDA ) has granted 510(k) clearance for X-trodes' Smart Skin solution (marketed as X-trodes System M), a new wireless wearable technology for advanced electrophysiological monitoring. X-trodes' technology is backed by more than 15 years of research at Prof.
The robotic technology represented an entirely novel way to address heart rhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. Gery Tomassoni , Director of Electrophysiology at Baptist Health Lexington.
Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. As electrophysiologists, our primary goal is to improve the lives of our patients,” said Dr. Mario Volpicelli , Head of the Electrophysiology Unit of the hospital. added Giuseppe Russo, General Manager of the Hospital Santa Maria della Pietà. “We
Davie-based HCA Florida University Hospital opened a new electrophysiology lab and is the first in the country to use new technology in the lab, it said in a May 30 news release.
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.
A key focus of the research was heart rate variability (HRV)analyzed using our AI-powered ECG technology. Our work spans cardiac electrophysiology, metabolic research, and AI-driven ECG analysis. These commonly used anti-inflammatory drugs often cause insulin resistance, high cholesterol, and muscle loss.
David Luria (left), Director of Electrophysiology at Hadassah Medical Center, and Ziv Menshes (right), CEO of CardioVia tim.hodson Tue, 04/08/2025 - 14:38 April 7, 2025 CardioVia, a medical device company specializing in advanced cardiac care solutions, has received U.S. Food and Drug Administration (FDA) clearance for its ViaOne system.
electrophysiology labs. These reductions in cost and carbon emissions will help shape conversations around the value of medical technology re-use at the annual Heart Rhythm Society conference in Boston. I believe they are truly adopting a sense of resource stewardship that is so badly needed in electrophysiology today.
Fluoroscopy-guided procedures are the leading source of occupational ionizing radiation exposure for electrophysiologic (EP) personnel. RSS may have an important role in full-body protection to all medical personnel from scattered radiation during electrophysiologic and cardiovascular implantable electronic device procedures.
Rapid technologic development and expansion of procedural expertise have led to widespread proliferation of catheter-based electrophysiology procedures. It is unclear whether these advances come at cost to patient safety.
We were an early adopter of this technology, mapping epicardial early sites of ventricular activation both in the operating room and in the Electrophysiology (EP) laboratory for certain arrhythmiasablation of accessory pathways (AP) not being one of them.
Recent progress in technology and clinical electrophysiology has led to detailed characterization of re-entry circuits and effective ablation strategies. The present review discusses the epidemiology, mechanisms, ECG characteristics, electrophysiological characterization, and catheter ablation of atypical AFL.
Personalized heart digital twin technology presents a noninvasive method of predicting critical substrate in VT, and its integration into clinical VT ablation offers a promising solution. Digital twin technology may help improve substrate-based VT ablation.REGISTRATION:URL:[link] Unique identifier: NCT04632394.
The electrophysiology community has long awaited innovation in robotic catheter technology and we are excited to support this progress.” Račkauskas. The catheter was very stable, effective and safe. We look forward to continued enrollment in the coming weeks.
Among the most innovative applications of this technology are medical chatbots, which have the potential to revolutionize the way health advice and information are delivered to patients. We explored this ability by using an example from the field of cardiac electrophysiology.
The filing for approval of this product family follows the FDA approval of BioCardia’s Helix biotherapeutic delivery Morph DNA guide system and its Avance transseptal steerable introducer, both of which incorporate Morph DNA technology.
Access to Cutting-Edge Techniques Many fellowships expose participants to the latest technologies and innovations in their field. For example, transitioning from general cardiology to interventional cardiology or electrophysiology. Career Plateau If you feel your career growth has stagnated, a fellowship can open new doors.
The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept.
said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. director of electrophysiology, Mount Sinai Fuster Heart Hospital , New York. physicians and patients alike," Reddy added.
In clinical practice, substrates are usually identified during electrophysiological mapping procedures using bipolar electrograms (EGM). Atrial conduction abnormalities are common among patients with congenital heart disease, predisposing them to arrhythmias.
2 Likewise, improved technologies and procedural techniques, better selection of patients, and favorable safety outcomes have resulted in more widespread use of ablation for VT. In the past decade, major advances were made in catheter ablation for arrhythmias and implantation of cardiac implantable electronic devices.1
Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablation therapy in underserved regions of Africa. A detailed assessment of such a solution has been prepared, confirming the technology, logistics and operations are viable.
electrophysiology labs, and will be participating in the Heart Rhythm Society annual meeting, HRS 2024, May 16-19 in Boston, MA. electrophysiology labs. electrophysiology labs, and will be participating in the Heart Rhythm Society annual meeting, HRS 2024, May 16-19 in Boston, MA. electrophysiology labs.
These technologies are compatible exclusively with Boston Scientific's existing cardiac mapping technology and the company's latest offering, the OPAL HDx Mapping System. director of electrophysiology, Mount Sinai Fuster Heart Hospital, New York.
JACC is also integrating with JACC: Clinical Electrophysiology to leverage that team's deep expertise and collaborating with JACC: Case Reports to highlight case studies and show commitment to frontline clinicians. The FDA and the Cardiovascular Community,” – A commentary from Haider J.
It might have been graduation time in many parts of Boston last weekend, but an electrophysiology family reunion was taking place in the city’s Seaport district, bringing the latest in EP science, technology, and patient care. and leveraging data from nearly as broad of a range of modalities (ECG, imaging, implants, catheter.).
Pulsed-field ablation (PFA) is becoming increasingly relevant in the field of electrophysiology. Besides single-shot PFA devices for pulmonary vein isolation (PVI), point-by-point PFA is also gaining importance due to many possible applications. Data on the use is sparse, especially for atrial tachycardia (AT).
Rapid changes in both device technology and the field of electrophysiology (EP) necessitate a growing need for continuing medical education and intraoperative support.
Novel technologies and ablation techniques for identification of AF sources and personalized substrate modification may be required to improve outcomes for persistent AF.
Artificial intelligence (AI) is increasingly used in daily practice in electrophysiology and cardiovascular medicine. It is thus of great importance to understand the promise and pitfalls of these technologies, both medical grade and direct-to-consumer, to be able to interpret their results to guide patients.
The first procedures, performed by leading physicians Saibal Kar , MD, FACC, FSCAI, (Program Director, Cardiovascular Disease Fellowship, Los Robles Health System , California, HCA Healthcare National Physician Director, Interventional Cardiology) and Devi Nair , MD, FACC, FHRS, (Director, Cardiac Electrophysiology Division, St.
Food and Drug Administration (FDA) in July 2023, a new leadless pacemaker system placed in both chambers of the heart and using a novel communication technology is now offering a more minimally invasive option for patients. Approved by the U.S. UC San Diego Health implanted the pacemaker system in the first patient in February 2024. “To
a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.
This week, the Cleveland Clinic enrolled the first patient in the AVANT GUARD trial, overseen by Dr. Oussama Wazni, vice chair of cardiovascular medicine and section head, Cardiac Electrophysiology and Pacing, Cleveland Clinic, who is also serving as the lead investigator of the trial. Circulation.
Abstract Introduction With the entry of pulsed-field ablation (PFA) into electrophysiology, new possibilities for ablation of different substrates such as epicardial foci of premature ventricular contractions (PVCs) from coronary venous system (CVS) have been opened.
Atrial fibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.
Abstract Introduction Due to its unique features, pulsed field ablation (PFA) could potentially overcome some limitations of current radiofrequency (RF) ventricular tachycardia (VT) ablation. However, data on the use of PFA in this setting are currently scarce.
No longer it’s only about digital dashboards, but technology is transforming all areas in Cath labs. However, not all software is built the same as many don’t keep up with changing requirements and technological advancements. With SoftCath, you can easily carry out Electrophysiology, manage data recovery, and clinical research.
The term, VT mapping has been in vogue in clinical electrophysiology for more than half a century, right from Dr.Josephson and Wellens’ days. We must thank the technological innovators in the electro-anatomical mapping system, who are continuously upgrading and providing the best to us.
They should be made aware of all the radiation protection measures in the interventional cardiology or specialized electrophysiology device training programs. If possible, make use of the vessel road-mapping technology, to reduce the additional fluoro requirement. This will minimize the exposure to half of what it would be otherwise.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. New catheter technology has recently integrated more accurate tissue temperature sensing enabling temperature-controlled irrigated ablation.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content